XML 77 R64.htm IDEA: XBRL DOCUMENT v3.10.0.1
Shareholders' Equity (Stock Options) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Unrecognized compensation cost $ 21.3    
Weighted average period costs expected to be recognized (in years) 3 years 3 months 1 day    
Stock Options and Stock Appreciation Rights (SARs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant date fair value of Stock options & SARs (in dollars per share) $ 14.78 $ 10.07 $ 8.61
Expected stock price volatility (percent) 25.69% 27.63% 26.88%
Risk-free interest rate (percent) 2.62% 2.11% 1.45%
Expected annual dividend yield (percent) 1.34% 1.87% 2.10%
Expected term of option & SARs (in years) 5 years 8 months 4 days 5 years 9 months 26 days 5 years 11 months 26 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Number of shares outstanding, Beginning Balance 2,308    
Number of shares, Granted 839    
Number of shares, Forfeited (123)    
Number of shares, Exercised (173)    
Number of shares outstanding, Ending Balance 2,851 2,308  
Number of shares, Exercisable 797    
Number of shares, Stock options & SARs expected to vest 2,053    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]      
Weighted average exercise price, Beginning Balance (in dollars per share) $ 42.75    
Weighted average exercise price, Granted (in dollars per share) 59.64    
Weighted average exercise price, Forfeited (in dollars per share) 44.59    
Weighted average exercise price, Exercised (in dollars per share) 42.20    
Weighted average exercise price, Ending Balance (in dollars per share) 47.67 $ 42.75  
Exercisable, Weighted Average Exercise Price (in dollars per share) 43.23    
Stock options & SARs expected to vest, Weighted Average Exercise Price (in dollars per share) $ 49.40    
Weighted average remaining contractual term, options outstanding (in years) 7 years 9 months 5 days    
Weighted average remaining contractual term, options exercisable (in years) 6 years 8 months 16 days    
Aggregate intrinsic value, options outstanding $ 47.2    
Aggregate intrinsic value, options exercisable 16.7    
Aggregate intrinsic value $ 4.2 $ 2.7 $ 1.4
Restricted Stock Units (RSUs) and Performance Share Units (PSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Number of shares outstanding, Beginning Balance 228    
Number of shares, Granted 31    
Number of shares, Vested (66)    
Number of shares, Forfeited (6)    
Number of shares outstanding, Ending Balance 187 228  
Share-based Compensation Arrangement by Share-based Payment Award, Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted average grant date fair value, Beginning Balance (in dollars per share) $ 41.66    
Weighted average grant date fair value, Granted (in dollars per share) 61.76 $ 48.32 $ 40.27
Weighted average grant date fair value, Vested (in dollars per share) 45.81    
Weighted average grant date fair value, Forfeited (in dollars per share) 45.03    
Weighted average grant date fair value, Ending Balance (in dollars per share) $ 43.46 $ 41.66  
Total fair value of shares vested $ 3.0 $ 3.4 $ 4.7